| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505 [M. D., F. C., D. P., J. Y., X. S., V. C., V. V.], and The Hormel Institute, University of Minnesota, Austin, Minnesota 55912 [Z. D., W-Y. M.]
Activation of activator protein (AP-1) by crocidolite asbestos was examined in vitro in a JB6 P+ cell line stably transfected with AP-1-luciferase reporter plasmid and in vivo using AP-1-luciferase reporter transgenic mice. In in vitro studies, crocidolite asbestos caused a dose- and time-dependent induction of AP-1 activation in cultured JB6 cells. The elevated AP-1 activity persisted for at least 48 h. Crocidolite asbestos also induced AP-1 transactivation in the pulmonary and bronchial tissues of transgenic mice. AP-1 activation was observed at 2 days after intratracheal instillation of the mice with asbestos. At 3 days postexposure, AP-1 activation was elevated 10-fold in the lung tissue and 22-fold in bronchiolar tissue as compared with their controls. The induction of AP-1 activity by asbestos appeared to be mediated through the activation of mitogen-activated protein kinase family members, including extracellular signal-regulating protein kinase, Erk1 and Erk2. Aspirin inhibited asbestos-induced AP-1 activity in JB6 cells. Pretreatment of the mice with aspirin also inhibited asbestos-induced AP-1 activation in bronchiolar tissue. The data suggest that further investigation of the role of AP-1 activation in asbestos-induced cell proliferation and carcinogenesis is warranted. In addition, investigation of the potential therapeutic benefits of aspirin in the prevention/amelioration of asbestos-induced cancer is justified.
This article has been cited by other articles:
![]() |
W. A. Swain, K. J. O'Byrne, and S. P. Faux Activation of p38 MAP kinase by asbestos in rat mesothelial cells is mediated by oxidative stress Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L859 - L865. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Gao, A. Zuberi, M. J. Quon, Z. Dong, and J. Ye Aspirin Inhibits Serine Phosphorylation of Insulin Receptor Substrate 1 in Tumor Necrosis Factor-treated Cells through Targeting Multiple Serine Kinases J. Biol. Chem., June 27, 2003; 278(27): 24944 - 24950. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Upadhyay and D. W. Kamp Asbestos-Induced Pulmonary Toxicity: Role of DNA Damage and Apoptosis Experimental Biology and Medicine, June 1, 2003; 228(6): 650 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. M. Reddy and B. T. Mossman Role and regulation of activator protein-1 in toxicant-induced responses of the lung Am J Physiol Lung Cell Mol Physiol, December 1, 2002; 283(6): L1161 - L1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Flaherty, M. M. Monick, A. B. Carter, M. W. Peterson, and G. W. Hunninghake Oxidant-Mediated Increases in Redox Factor-1 Nuclear Protein and Activator Protein-1 DNA Binding in Asbestos-Treated Macrophages J. Immunol., June 1, 2002; 168(11): 5675 - 5681. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L. Zhao, C. Q. Piao, L. J. Wu, M. Suzuki, and T. K. Hei Differentially expressed genes in asbestos-induced tumorigenic human bronchial epithelial cells: implication for mechanism Carcinogenesis, November 1, 2000; 21(11): 2005 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ding, X. Shi, Z. Dong, F. Chen, Y. Lu, V. Castranova, and V. Vallyathan Freshly Fractured Crystalline Silica Induces Activator Protein-1 Activation through ERKs and p38 MAPK J. Biol. Chem., October 22, 1999; 274(43): 30611 - 30616. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ye, P. Zeidler, S.-h. Young, A. Martinez, V. A Robinson, W. Jones, P. Baron, X. Shi, and V. Castranova Activation of Mitogen-activated Protein Kinase p38 and Extracellular Signal-regulated Kinase Is Involved in Glass Fiber-induced Tumor Necrosis Factor-alpha Production in Macrophages J. Biol. Chem., February 9, 2001; 276(7): 5360 - 5367. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |